Metallothioneins (MTs) are ubiquitous low molecular weight proteins
and polypeptides of extremely high metal and sulfur content. They are
thought to play roles both in the intracellular fixation of the
essential trace elements zinc and copper, in controlling the
concentrations of the free ions of these elements, in regulating their
flow to their cellular destinations, in neutralising the harmful
influences of exposure to toxic elements such as cadmium and mercury
and in the protection from of a variety of stress conditions
(Kägi & Schäffer 1988).
MT was discovered in 1957 when Margoshes and Vallee (1957) identified in equine kidney cortex a cadmium-binding protein responsible for the natural accumulation of cadmium in this tissue. MTs are still the only biological compounds known to naturally contain this metal. However, as already shown in the earliest studies, cadmium is the only one of several optional metallic components, the others being most commonly zinc and copper (Kägi & Vallee 1960, Pulido et al. 1966). Thus, MTs are key compounds involved in the intracellular handling of a variety of essential and nonessential post-transition metal ions.
Definition. MTs have received their designation
from their prominent metal and sulfur content which, varying with the
metal species present, together may contribute to over 20% of their
weight. The mammalian forms are characterized by a molecular weight of
6000-7000 Da, containing 60 to 68 amino acid residues, among them 20
Cys, and binding a total of 7 equiv. of bivalent metal ions. Aromatic
amino acids are usually absent. All Cys occur in the reduced form and
are coordinated to the metal ions through mercaptide bonds, giving
rise to spectroscopic features characteristic of metal-thiolate
clusters. According to the recommendations made by The Committee on
the Nomenclature of MT any protein or polypeptide resembling
mammalian MTs in several of these criteria can be classified as an MT
(Fowler et al. 1987).
Occurrence. MTs occur throughout the animal kingdom and are also found in higher plants, eukaryotic microorganisms, and in some prokaryotes (see the metallo.txt file associated with SWISS-PROT). In animals, the genetically polymorphous proteins are most abundant in parenchymatous tissues, i.e. liver, kidney, pancreas, and intestines. There are wide variations in concentration in different species and tissues, reflecting effects of age, stage of development, dietary regimen, and other not yet fully identified factors. Although MT is a cytoplasmic protein, it can also accumulate in lysosomes, and during development it is observed in the nucleus.
Spatial structure. Spatial structures of mammalian MTs,
crustacean MTs and an echinodermal MT have been derived from 2D NMR
spectroscopy and X-ray crystallography. Alhough their amino acid
sequences are very different, they have similar spatial
structures. They all have a dumbell-like shape with two separate
protein domains containing in their core mineral-like clusters built up
of several tetrahedral Me(II)-Cys units. All Cys are involved in the binding
of the metals. MTs contain almost no regular secondary
structure elements.
Molecular evolution. Phylogenetic relationships of the various MT
families have recently been established by different methods and
approaches both from protein and gene MT sequences. The results of the
analyses lead to the diferentiation into a variety of phylogenetically
related subfamilies and subgroups and have allowed to derive an
evolutionary pedigree for the highly complex vertebrate family (Binz
1996, Binz & Kägi poster, Binz 1999)
Molecular genetics. MTs are genetically polymorphous
protein families with subfamilies, subgroups and isoforms. In vertebrates
all MT genes are
divided into a 5' flanking region (5'UT), a 5' untranslated region
(5'UTR), 3 coding exons separated by 2 introns and a 3' flanking end. Mammals
possess genes for four subfamilies, the ubiquitous MT-1 and MT-2, the
brain specific MT-3 and the squamous epithelium specific MT-4. All are
located on a single chromosome, i.e. chromosome 8 in mouse and
chromosome 16 in human (Quaife et al. 1994). The 5'UT contains regulatory elements among
them one or more copies of the metal responsive element (MRE)
(Stuart et al. 1985) which
acts as a binding target for the transcription activating protein factor
(MTF-1) (Brugnera et al. 1994) regulating MT-gene
expression.
Functional aspects. The most conspicious biological
feature of the MTs is their inducibility by a variety of agents and
conditions. Thus, their biosynthesis of many MTs is greatly enhanced
both in vivo and in cultured cells by transition and d10 metal ions
and by certain hormones,
cytokines, growth factors, tumor promoters and many other chemicals. A
massive accretion of MT is also observed in the livers of animals
submitted to physical stress. Physiological MT-synthesis and MT
concentrations are increased transiently several folds during cell
proliferation. MT interchanges its zinc with zinc-finger proteins in
vitro and hence, may imply a contributory role of MT to zinc-dependent
processes involved in gene expression.
References:
Binz P.-A. (1996) PhD thesis, University Zürich, Zürich,
Switzerland
Binz P.-A. & Kägi J.H.R. (1996) poster presentation, Protein
Science 6, suppl. 1, p 68
Binz, P.-A., Kägi, J.H.R. Metallothionein: Molecular evolution and
classification. (1999) In: Metallothionein IV, C. Klaassen (ed.),
Birkhäuser Verlag Basel, 7-13
Brugnera E., Georgiev O., Radtke F., Heuchel R., Baker E., Sutherland G.R.
& Schaffner W. (1994) Nucleic Acids Res 22, 3167-3173
Fowler B.A., Hildebrand C.E., Kojima Y. & Webb M. (1987) Experientia
Suppl. 52, 19-22
Kägi J.H.R. & Schäffer A. (1988) Biochemistry 27,
8509-8515
Kägi J.H.R. & Vallee B.L. (1960) J. Biol. Chem. 235,
3460-3465
Margoshes M. & Vallee B.L. (1957) J. Am. Chem. Soc. 79,
4813-4814
Pulido P., Kägi J.H.R. & Vallee B.L. (1966) Biochemistry 5,
1768-1777
Quaife C.J., Findley S.D., Erickson J.C., Froelick G.J., Kelly E.J.,
Zambrovic B.P. & Palmiter R.D. (1994) Biochemistry 33, 7250-7259
Stuart G.W., Searle P.F. & Palmiter R.D. (1985) Nature 317,
828-831